glp-1 drugs and addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) substance use disorders: An emerging pharmacotherapeutic target New Study Suggests GLP-1 Medications
Description
doi: 10.1590/S0100-879X2002000500011 151 OnoviranO
Those with more acute symptoms often landed up spending many months in hospital being given a range of bland diets or milk drips
Ozempic blindness isnt a real diagnosis
edited and revised manuscript
